With the advancement of Smart Technologies, more and more pharmaceutical companies are becoming aware of the fact that digitalization, computerization, transformation and intelligent production have every day a leading role within the business development plan. Especially the improvement of quality, a controlled yield of drugs and the reduction of costs through digitalization take on significant importance in terms of production efficiency.
The IMA Group will talk about new technologies and technological advancement in the pharmaceutical field during the CPHI CHINA & P-MEC 2020 trade fairs, this last main Asian international event focused on pharmaceutical machinery. For the first time in hybrid mode, both physical and virtual, the fair offers learning and networking opportunities for decision makers in pharmaceutical manufacturing and engineering. The appointment with the P-MEC China 2020 is scheduled this year from 16 to 18 of December 2020 at the SNIEC – New International Expo Center in Shanghai.
The IMA Group’s participation in the event in question will see the joint partnership of IMA Life, a Division of the Group leader in the design and construction of automatic machines and complete lines for aseptic and freeze-drying processes, and IMA Digital, a global project promoted by the Group for the creation of technologies relating to Smart Production.
Within the Forum dedicated to the Digitization of Pharmaceutical Production 2020, the IMA Group will hold the speech:
During the speech, it will be illustrated how the most advanced digital technologies can optimize and make production processes more and more efficient. From Digital Services for remote assistance and virtual technologies related to production, passing through the Smart Training offers, developed to meet the most diverse training needs of operators and engineers within the production lines. The goal is to create advanced technologies capable of making production flows more and more efficient.
For any further information,